Intravitreal Tissue Plasminogen Activator Injection for Treatment-Resistant Diabetic Macular Edema of the Vitrectomized Eye
Diabetic macular edema (DME) is the main cause of visual loss in patients with diabetic retinopathy. DME has been treated using intravitreal anti-vascular endothelial growth factor (VEGF) drugs, steroids, laser photocoagulation, vitreoretinal surgery, and their combinations. These modalities are gen...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Karger Publishers
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/a7bc3bcbc55f46a5a30e91fc8cfbb2e9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|